Veracyte, Inc. logo VCYT - Veracyte, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 6
SELL 1
STRONG
SELL
0
| PRICE TARGET: $45.25 DETAILS
HIGH: $52.00
LOW: $37.00
MEDIAN: $46.00
CONSENSUS: $45.25
UPSIDE: 0.49%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Revenue
Revenue 517.1 445.8 361.1 296.5 219.5 117.5 120.4 92.0 72.0 65.1 49.5 38.2 21.9 11.6 2.6
Cost of Revenue 157.1 147.6 112.9 101.6 74.4 41.5 36.5 33.1 28.2 25.5 21.5 16.6 12.6 7.6 2.9
Gross Profit 360.0 298.1 248.1 195.0 145.1 76.0 83.8 58.9 43.8 39.6 28.0 21.6 9.3 4.0 (0.3)
Operating Expenses
R&D Expenses 70.8 69.3 57.3 40.6 29.8 17.2 14.9 14.8 13.9 15.3 12.8 9.8 7.8 6.6 6.7
SG&A Expenses 210.9 206.0 184.2 174.1 181.2 89.1 82.7 65.3 55.3 52.0 47.9 40.8 24.6 16.4 8.3
Other Expenses 4.1 6.7 92.4 21.4 16.0 5.1 1.4 1.2 0.5 0.2 0.1 0.1 0 0 0
Operating Expenses 285.9 282.0 333.9 236.0 227.0 111.4 99.0 81.2 70.3 68.4 61.5 50.6 32.5 23.0 15.0
Operating Income
Operating Income 74.2 16.1 (85.8) (41.1) (81.9) (35.4) (15.1) (22.2) (26.5) (28.8) (33.5) (29.0) (23.2) (18.9) (15.3)
Interest Expense 0 0.0 0.0 0.2 0.2 0.2 0.7 2.0 4.9 2.8 0.4 0.4 0.2 0 0
Interest Income 0 11.2 7.3 2.0 0.1 0.6 3.0 0 0 0 0 0 0.0 0.0 0.0
Profitability
EBITDA 89.6 49.2 (49.4) (7.0) (60.2) (26.7) (7.8) (17.1) (23.8) (25.1) (32.5) (27.8) (24.3) (17.9) (13.8)
EBIT 68.2 25.7 (76.6) (36.2) (81.4) (34.7) (11.9) (21.0) (27.6) (28.7) (33.3) (28.9) (25.3) (18.6) (14.4)
Income Before Tax 68.2 25.7 (76.6) (36.4) (81.6) (34.9) (12.6) (23.0) (31.0) (31.4) (33.7) (29.4) (25.6) (18.6) (14.4)
Income Tax Expense 1.8 1.6 (2.2) 0.1 (6.1) 0 0 0 0 0 0 0 0 (0.0) 0
Net Income 66.4 24.1 (74.4) (36.6) (75.6) (34.9) (12.6) (23.0) (31.0) (31.4) (33.7) (29.4) (25.6) (18.6) (14.4)
Per Share Data
EPS (Basic) 0.84 0.32 -1.02 -0.51 -1.11 -0.66 -0.27 -0.62 -0.91 -1.09 -1.30 -1.36 -6.15 -1.31 -1.02
EPS (Diluted) 0.82 0.31 -1.02 -0.51 -1.11 -0.66 -0.27 -0.62 -0.91 -1.09 -1.30 -1.36 -6.15 -1.31 -1.02
Shares Outstanding 78.6 76.5 72.6 71.5 67.9 53.2 46.1 37.0 33.9 28.8 25.9 21.6 4.2 14.2 14.2
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 362.6 239.1 216.5 154.2 173.2 349.4 159.3 78.0 33.9 59.2
Short-Term Investments 50.3 50.4 0 24.6 4.0 0 0 0 0 0
Net Receivables 44.7 46.5 40.4 44.0 41.5 18.5 19.3 13.2 12.7 8.8
Inventory 20.5 21.8 16.1 14.3 11.2 4.7 6.8 3.4 5.3 3.5
Other Current Assets 10.3 14.6 12.7 11.5 (4.0) 0 0 0 2.0 0.3
Total Current Assets 488.4 372.3 285.6 248.6 243.1 375.7 187.7 97.0 53.9 73.6
Non-Current Assets
Property, Plant & Equipment 58.8 71.1 30.9 30.9 31.1 16.8 17.7 8.9 9.7 11.5
Goodwill 767.2 745.8 703.0 695.9 707.9 2.7 2.7 1.1 1.1 1.1
Intangible Assets 89.1 102.3 88.6 174.9 202.7 59.9 65.0 12 13.1 14.1
Long-Term Investments 0 0 0 0 0 0 0 0.6 0.6 0.6
Other Non-Current Assets 2.5 8.5 6.8 6.2 2.9 2.0 2.0 1.7 0.9 0.7
Total Non-Current Assets 917.6 927.8 829.3 907.8 944.7 81.5 87.5 23.7 24.7 27.4
Total Assets 1,406.0 1,300.0 1,114.9 1,156.4 1,187.8 457.2 275.2 120.6 78.7 101.0
Current Liabilities
Account Payables 4.6 8.6 12.9 11.9 12.4 3.1 2.3 2.5 3.9 2.4
Short-Term Debt 4.1 0 0 0 1.1 0 0 1.4 0 0
Deferred Revenue 1.2 1.7 2.0 2.6 4.6 0.4 0 0 0 0
Other Current Liabilities 50.1 47.6 29.2 36.9 33.7 9.2 10.1 0 0 0
Total Current Liabilities 59.9 78.6 61.2 62.6 64.2 16.8 17.5 13.1 12.0 11.5
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0.8 0.7 23.9 24.9 24.9
Deferred Tax Liabilities 0.6 1.2 0.7 4.5 5.6 0 0 0 0 0
Other Non-Current Liabilities 0.3 1.0 1.3 3.4 7.1 7.6 6.1 3.9 4.2 4.4
Total Non-Current Liabilities 36.5 45.4 9.6 18.6 27.2 19.1 18.3 27.8 29.4 29.9
Total Liabilities 96.4 124.1 70.8 81.2 91.3 35.9 35.8 40.9 41.4 41.5
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0
Retained Earnings (377.6) (444.0) (468.1) (393.7) (357.2) (281.6) (246.7) (234.1) (211.1) (180.1)
Accumulated Other Comprehensive Income (8.2) (36.1) (24.0) (31.3) (15.1) 0 0 (12.0) (9.3) (6.8)
Total Stockholders' Equity 1,309.6 1,176.0 1,044.1 1,075.2 1,096.5 421.2 239.5 79.8 37.2 59.6
Total Liabilities & Equity 1,406.0 1,300.0 1,114.9 1,156.4 1,187.8 457.2 275.2 120.6 78.7 101.0
Debt Metrics
Total Debt 39.7 50.7 12.6 14.7 18.9 12.3 13.6 25.3 25.2 25.5
Net Debt (322.9) (188.3) (203.8) (139.5) (154.3) (337.0) (145.7) (52.7) (8.6) (33.7)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income 66.4 24.1 (74.4) (36.6) (75.6) (34.9) (12.6) (23.0) (31.0) (31.4)
Depreciation & Amortization 21.4 23.5 27.2 25.9 19.6 7.9 4.1 3.9 3.8 3.5
Stock-Based Compensation 43.6 36.2 33.1 26.7 22.5 13.0 9.8 6.0 6.6 6.4
Change in Working Capital (2.3) (21.3) (4.2) (16.4) 4.2 (0.5) (4.8) (0.7) (5.4) (6.4)
Other Non-Cash Items 7.8 12.8 66.3 7.7 3.9 4.7 0.3 0.3 2.1 (0.2)
Operating Cash Flow 136.3 75.1 44.2 7.5 (31.6) (9.7) (3.2) (13.5) (23.9) (28.0)
Investing Activities
Capital Expenditure (9.7) (11.3) (10.0) (8.5) (5.4) (2.8) (2.8) (1.9) (1.8) (4.2)
Acquisitions (2.8) 5.0 0 0 (736.8) 0 (40) 0 0.4 0
Purchases of Investments (150.0) (50) (19.7) (33.5) 162.4 (1) 0 0 0 0
Sales/Maturities of Investments 153.3 0 44.8 12.7 3 0 0 0 0 0
Other Investing Activities 0 0 0 0 (162.4) 0 0.0 0 0.6 (0.0)
Investing Cash Flow (9.2) (56.3) 15.1 (29.4) (739.2) (3.8) (42.7) (1.9) (1.2) (4.2)
Financing Activities
Net Debt Issuance 0 0 0 (1.3) 0 (0.1) (25.2) (0.3) (2.3) 19.2
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (18.3) (15.1) 2.8 4.8 2.5 9.9 14.6 4.8 1.9 1.2
Financing Cash Flow (4.2) 4.9 2.8 3.5 596.3 203.6 127.3 59.5 (0.2) 52.3
Cash Position
Net Change in Cash 123.6 23.3 62.3 (18.9) (176.0) 190.0 81.3 44.1 (25.3) 20.1
Cash at Beginning 240.6 217.3 155.0 173.9 350.0 159.9 78.6 34.5 59.2 39.1
Cash at End 364.2 240.6 217.3 155.0 173.9 350.0 159.9 78.6 33.9 59.2
Free Cash Flow 126.6 63.8 34.3 (1.0) (37.0) (12.5) (6.0) (15.4) (25.7) (32.2)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Income Statement
Revenue 517.1 445.8 361.1 296.5 219.5 117.5 120.4 92.0 72.0 65.1 49.5 38.2 21.9 11.6 2.6
Gross Profit 360.0 298.1 248.1 195.0 145.1 76.0 83.8 58.9 43.8 39.6 28.0 21.6 9.3 4.0 (0.3)
Operating Income 74.2 16.1 (85.8) (41.1) (81.9) (35.4) (15.1) (22.2) (26.5) (28.8) (33.5) (29.0) (23.2) (18.9) (15.3)
Net Income 66.4 24.1 (74.4) (36.6) (75.6) (34.9) (12.6) (23.0) (31.0) (31.4) (33.7) (29.4) (25.6) (18.6) (14.4)
EPS (Diluted) 0.82 0.31 -1.02 -0.51 -1.11 -0.66 -0.27 -0.62 -0.91 -1.09 -1.30 -1.36 -6.15 -1.31 -1.02
Balance Sheet
Cash & Equivalents 362.6 239.1 216.5 154.2 173.2 349.4 159.3 78.0 33.9 59.2
Total Assets 1,406.0 1,300.0 1,114.9 1,156.4 1,187.8 457.2 275.2 120.6 78.7 101.0
Total Debt 39.7 50.7 12.6 14.7 18.9 12.3 13.6 25.3 25.2 25.5
Stockholders' Equity 1,309.6 1,176.0 1,044.1 1,075.2 1,096.5 421.2 239.5 79.8 37.2 59.6
Cash Flow
Operating Cash Flow 136.3 75.1 44.2 7.5 (31.6) (9.7) (3.2) (13.5) (23.9) (28.0)
Capital Expenditure (9.7) (11.3) (10.0) (8.5) (5.4) (2.8) (2.8) (1.9) (1.8) (4.2)
Free Cash Flow 126.6 63.8 34.3 (1.0) (37.0) (12.5) (6.0) (15.4) (25.7) (32.2)